Xyosted™ (testosterone enanthate) – New formulation approval
October 1, 2018 - Antares Pharma announced the FDA approval of Xyosted (testosterone enanthate), for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.
Download PDF
